Fludarabine and cyclophosphamide is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. The lead sponsor is Affiliated Hospital to Academy of Military Medical Sciences. Registered phase: Phase EARLY_PHASE1. Conditions studied include Relapsed or Refractory Plasma Cell Neoplasms; Lymphomas/Leukemias With Plasmacytic Differentiation; High-risk Plasma Cell Neoplasms.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07416682 | CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms (ClinicalTrials.gov ↗) High-risk Plasma Cell Neoplasms |
Phase EARLY_PHASE1 | Recruiting |
| NCT06986434 | CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation (ClinicalTrials.gov ↗) Relapsed or Refractory Plasma Cell Neoplasms, Lymphomas/Leukemias With Plasmacytic Differentiation |
Phase EARLY_PHASE1 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Relapsed or Refractory Plasma Cell Neoplasms | 1 |
| Lymphomas/Leukemias With Plasmacytic Differentiation | 1 |
| High-risk Plasma Cell Neoplasms | 1 |
| Lead sponsor | Trials |
|---|---|
| Affiliated Hospital to Academy of Military Medical Sciences | 2 |
| Register | Fludarabine and cyclophosphamide trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Fludarabine and cyclophosphamide works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Fludarabine and cyclophosphamide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.